BlinatumomabDevelopment of drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1847卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92658-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：101 / 101

相关论文

共 50 条

[41] MeropenemDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1785 (1) : 329 - 329
[42] IsoniazidDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1874 (1) : 150 - 150
[43] ImatinibDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1809 (1) : 128 - 128
[44] DolutegravirAcquired drug resistance: case report
Reactions Weekly, 2023, 1962 (1) : 165 - 165
[45] AlectinibAcquired drug resistance: case report
Reactions Weekly, 2023, 1960 (1) : 24 - 24
[46] CotrimoxazoleDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1823 (1) : 129 - 129
[47] RifampicinAcquired drug resistance: case report
Reactions Weekly, 2020, 1810 (1) : 182 - 182
[48] AntineoplasticsDevelopment of drug resistance: case report
Reactions Weekly, 2019, 1782 (1) : 37 - 37
[49] MeropenemAcquired drug resistance: case report
Reactions Weekly, 2018, 1729 (1) : 168 - 168
[50] TrastuzumabDevelopment of drug resistance: case report
Reactions Weekly, 2016, 1632 (1) : 300 - 300

← 1 2 3 4 5 →